Was expecting the Phase 1 results but wasn’t expecting it to need a trading halt. I’m fairly confident the safety box will be ticked yes, so it’s really the bioavailability box that I’m most excited about to see if it backs up the animal studies.
The company said previously they’d move to Phase 3 as soon as Phase 1 comes in so hopefully the need for the trading halt is to put the finished touches in the trial results announcement with a here’s what’s next final paragraph. Hopefully not to say the bioavailability was non remarkable which is kind of what the house of cards is built upon.
Smart money invested here with the extra options exercisable at 0.40 gives me confidence though, so I’ll be fairly sure they’ll get them too.
Hopeful the drama of a trading halt for a few week Phase 1 trial result will be because it exceeds all expectations!!!
Add to My Watchlist
What is My Watchlist?
